Xceed Molecular was formed in December 2003 and is focused on translating novel, multiplex biomarker signatures from research into routine clinical use. Xceed is headquartered in Toronto, ON Canada, with a USA office in Wellesley, MA.

In November 2007, Xceed launched the Ziplex Automated Gene-Expression System at the Association for Molecular Pathology Annual Meeting and announced its Strategic Collaborator Program - a mutually beneficial agreement with partners to advance their clinical research. Several strategic partners have already successfully demonstrated the utility of the Ziplex System in a
clinical setting.